Physician profile
Eli Simsolo
NPI 1811420458
$13,842.00
in general payments reported to CMS, 2019-2025
12 companies · $5,973 in 2025
The $5,973 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $428 · 2023: $3,021 · 2024: $4,420 · 2025: $5,973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,943 · Travel and Lodging: $2,323 · Grant: $1,880 · Education: $1,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,942.56 |
| Travel and Lodging | $2,322.71 |
| Grant | $1,880.28 |
| Education | $1,268.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,294.13 | 2023-2025 | Watchman Flx, Emblem Mri S-Icd, Farapulse |
| Medtronic, INC. | $3,930.12 | 2023-2025 | Micra, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $3,638.67 | 2021-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Biosense Webster, INC. | $665.65 | 2024-2025 | Carto 3 |
| Biotronik INC. | $651.92 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $243.44 | 2021-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $157.76 | 2025 | Lifevest |
| Amgen INC. | $115.15 | 2021-2025 | Repatha |
| Atricure, INC. | $54.48 | 2024-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Novartis Pharmaceuticals Corporation | $49.54 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $25.33 | 2025 | Eliquis |
| Baxter Healthcare | $15.81 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eli Simsolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.